Cargando…
A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
Lung adenocarcinoma (LUAD) is a highly invasive and metastatic malignant tumor with high morbidity and mortality. This study aimed to construct a prognostic signature for LUAD patients based on metastasis-associated genes (MAGs). RNA expression profiles were downloaded from the Cancer Genome Atlas (...
Autores principales: | Wang, Zhihao, Liu, Yusi, Zhan, Xiaoqian, Wang, Xi, Zhang, Chao, Qin, Lingzhi, Liu, Liwei, Qin, Shenghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320549/ https://www.ncbi.nlm.nih.gov/pubmed/35830566 http://dx.doi.org/10.18632/aging.204169 |
Ejemplares similares
-
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021) -
Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
por: Wang, Zhihao, et al.
Publicado: (2021) -
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021) -
Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
por: Embaye, Kidane Siele, et al.
Publicado: (2021) -
miR-223 promotes colon cancer by directly targeting p120 catenin
por: Liu, Liwei, et al.
Publicado: (2017)